Table 3

Groups	Cholesterol (mg/dl)	Triglycerides (mg/dl)	HDL-c (g/dl)	LDLc (g/dl)	VLDLc (g/dl)	Risk ratio
1^st	73.22±5.78^d	90.23±4.23^d	38.52±2.88^a	28.63±9.95^d	18.04±2.96^c	1.90±0.45^d
2^nd	269.32±11.03^a	220.75±10.66^a	5.45±2.45^e	58.63±7.09^a	44.15±3.41^a	49.41±0.55^a
3^rd	97.36±6.54^b	119.48±4.23^b	24.44±1.32^d	39.52±2.49^b	23.89±2.85^b	3.98±0.32^b
4^th	74.25±1.72^d	94.15±5.44c^d	32.36±3.98^b	29.75±4.60^cd	18.83±1.95^c	2.29±0.57^c
5^th	76.25±3.20c^d	93.20±2.10c^d	31.25±1.20^c	28.50±3.54^d	18.64±1.20^c	2.10±0.24^c

Data presented as mean ± S.E. (n=10). Means within the same column in each category carrying different litters are significant at (P ≤ 0.05) using Duncan's multiple range tests, where the highest mean value has the symbol (a) and decreasing in value were assigned alphabetically

Table 3: Effect of Metformin and Metformin/Cr+3 complex on the lipid profile in normal and diabetic rat.